We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTPI
11626
DELISTED
Petros Pharmaceuticals
PTPI
$45K ﹤0.01%
349
+63
+22% +$11.4K
TDUP icon
11627
PUT
ThredUp
TDUP
$403M
$45K ﹤0.01%
24,600
+9,500
+63% +$23.8K
UBX
11628
DELISTED
Unity Biotechnology
UBX
$45K ﹤0.01%
11,333
+2,267
+25% +$14.3K
YQ
11629
17 Education & Technology Group
YQ
$22.6M
$45K ﹤0.01%
+6,678
New +$58.7K
DWTX
11630
PUT
Dogwood Therapeutics
DWTX
$72.3M
$45K ﹤0.01%
+4,712
New +$664K
NPKI
11631
NPK International
NPKI
$1.21B
$45K ﹤0.01%
17,691
-21,388
-55% -$62.9K
AKTS
11632
PUT
DELISTED
Akoustis Technologies Inc
AKTS
$45K ﹤0.01%
15,300
-4,400
-22% -$17.9K
PRST
11633
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$45K ﹤0.01%
+21,805
New +$194K
SLGC
11634
CALL
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$45K ﹤0.01%
15,400
-15,600
-50% -$65.7K
CZOO
11635
CALL
DELISTED
Cazoo Group Ltd
CZOO
$45K ﹤0.01%
49
+40
+444% +$53.5K
RMO
11636
CALL
DELISTED
Romeo Power, Inc.
RMO
$45K ﹤0.01%
111,500
-61,500
-36% -$37K
ATIP
11637
DELISTED
ATI Physical Therapy, Inc.
ATIP
$45K ﹤0.01%
894
-8,189
-90% -$466K
YDKG
11638
CALL
Yueda Digital Holding
YDKG
$5.92M
$44K ﹤0.01%
175
-15
-8% -$6.88K
BDSX icon
11639
CALL
Biodesix
BDSX
$253M
$44K ﹤0.01%
1,745
-1,685
-49% -$65K
NBP
11640
CALL
NovaBridge Biosciences American Depositary Shares
NBP
$227M
$44K ﹤0.01%
10,900
-11,800
-52% -$89.5K
PBYI icon
11641
PUT
Puma Biotechnology
PBYI
$456M
$44K ﹤0.01%
+18,700
New +$54.6K
XFOR icon
11642
CALL
X4 Pharmaceuticals
XFOR
$418M
$44K ﹤0.01%
860
+37
+4% +$1.28K
VLD
11643
PUT
DELISTED
Velo3D, Inc.
VLD
$44K ﹤0.01%
+320
New +$41.6K
EXPR
11644
PUT
DELISTED
Express, Inc.
EXPR
$44K ﹤0.01%
2,040
-10
-0.5% -$342
ACGN
11645
DELISTED
Aceragen Inc
ACGN
$44K ﹤0.01%
6,849
-3,025
-31% -$22.8K
ASAP
11646
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$44K ﹤0.01%
15,100
+4,295
+40% +$23.4K
LGV.WS
11647
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$44K ﹤0.01%
625,406
-994
-0.2% -$132
APM
11648
DELISTED
Aptorum Group
APM
$43K ﹤0.01%
+3,711
New +$52.9K
DLPN icon
11649
CALL
Dolphin Entertainment
DLPN
$15.6M
$43K ﹤0.01%
8,150
+2,650
+48% +$22K
DLPN icon
11650
Dolphin Entertainment
DLPN
$15.6M
$43K ﹤0.01%
+8,093
New +$67.1K

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.